Plasminogen activator and pharmaceutical composition having thro

Details Plasminogen activator and pharmaceutical composition having thro Plasminogen activator and pharmaceutical composition having thro

1986-05-28

1988-06-21

Rosen, Sam

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 8, 530300, 530350, 530828, A61K 3700

Patent

active

047526033

ABSTRACT:
A new plasminogen activator which is very similar to the plasminogen activator from blood can be isolated in good amounts from the culture fluid of human melanoma cells.
This new plasminogen activator has a strong thrombolytic effect and pharmaceutical compositions thereof may be used in the therapeutic treatment of thrombosis disorders.

REFERENCES:
patent: 3904480 (1975-09-01), Hull et al.
patent: 4245051 (1981-01-01), Reich et al.
patent: 4259447 (1981-04-01), Hafeli
patent: 4317882 (1982-04-01), Horiguchi et al.
patent: 4370417 (1983-01-01), Hung et al.
Allen, Cell. Biol. 4, 803, (1980); Chemical Abstracts 93, No. 183281.
Angles-Cano et al., C.R. Hebd. Seances Acad. Sc. 289, 485 (1979); Chemical Abstracts 92, No. 3674m (1980).
Aoki, Journal Biochem. 75, 731 (1974).
Astrup et al., Arch. Biochem. Biophys. 40, 346 (1952).
Barlow et al., Proc. Serono Symp. 9, 75 (1977); Chemical Abstracts 89, No. 57188j (1978).
Binder et al., Journal of Biological Chemistry 254, 1998 (1979).
Camiolo et al., PSEBM 138, 277 (1971).
Christman et al., Proteinases in Mammalian Cells and Tissues, (A. J. Barrett, ed.; Elsvier, Amsterdam), pp. 91-149.
Collen, Edward Kowalski Memorial Lecture, Thromb Haem 43, 77 (1980).
Danoe et al., Biochemica et Biophysica Acta 613, 542 (1980); Chemical Abstracts 93, No. 90924b (1980).
Danoe et al., J. Exp. Med. 147, 745 (1978); Chemical Abstracts 88, No. 150159q (1978).
Fraki et al., J. Cutaneous Pathol. 6, 195 (1979); Chemical Abstracts 92, No. 445w (1980).
Granelli-Piperino et al., J. Exp. Medicine 148, 223 (1978).
Heussen et al., Analytical Biochemistry 102, 196 (1980); Chemical Abstracts 92, No. 89750q.
Klavina et al., Produtsenty Aminokisolot i Fermentov 1978, 94; Chemical Abstracts 89, No. 125054q (1978).
Ouchterlony, Progress in Allergy V, (P. Kallos, ed.), 1 (1958).
Petrenko, Purification and Properties of Plasminogen Activator from Human Blood Plasma after Sudden Death, p. 1127; Biokhimiya 43, 1438 (1978); Chemcial Abstracts 89, No. 192926p (1978).
Porath et al., Nature 258, 598 (1975).
Pye et al., Proc. Serono Symp. 9, 43 (1977); Chemical Abstracts 89, No. 159241p (1978).
Radcliffe et al., Archives of Biochemistry and Biophysics 189, 185 (1978).
Rijken et al., Biochemica et Biophysica Acta 580, 140 (1979); Chemical Abstracts 91, No. 170680t (1979).
Rijken, D. C., Plasminogen Activator from Human Tissue, Thesis pp. 1-125 (1980).
Rijken, D. C. et al., J. Biol. Chem. 256, 7035 (1981).
Roblin et al., Cancer Research 40, 2706 (1980); Chemical Abstracts 93, No. 126098b (1980).
Thorsen et al., Thrombos Diathes. haemorh 28, 65 (1972).
Thorsen, Danish Medical Bulletin 24, 189 (1977).
Shiba et al., JA 7844612, 21 Apr. 1978; Chemical Abstracts 89, No. 103261c (1978).
Vetterlein et al., J. Biol. Chem. 254, 575 (9179); Chemical Abstracts 90, No. 135631k (1979).
Vermylen et al., Clin. Chim. Acta 8, 418 (1963).
Wallen, Progress in Chemical Fibrinolysis and Thrombolysis, 3, 167.
Wang et al., Cancer Research 40, 288 (1980); Chemical Abstracts 92, No. 92449d.
Weber & Osborn, J. Biol. Chem. 244, 4406 (1969).
Wilson, E. L. et al., Chemical Abstracts 92, No. 144679a (1980).
Wu et al., Int. J. Biochem. 10, 1001 (1979); Chemical Abstracts 92, No. 54020z (1980).
Sumitomo Chemical Co., Jap. Kokai 79147993, 19 Nov. 1979; Chemical Abstracts 92, No. 106531p (1980).
Chemical Abstract Ninth Collection Index, 70-85, 29549cs (1972-1976).
Wiman et al., Nature 272, 549 (1978).

Affiliated with

Also associated with

Rating

Plasminogen activator and pharmaceutical composition having thro does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Plasminogen activator and pharmaceutical composition having thro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasminogen activator and pharmaceutical composition having thro will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-930014